Moomoo AI 已提取核心信息
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Virpax Pharmicals, Inc. [VRPX] 的举报人迈克尔·杜宾于2024年1月29日执行了一项交易。公告中没有披露交易的细节，包括所涉及的股票数量、股票的性质、交易价格和股票的总价值。没有具体说明迈克尔·杜宾与发行人的关系，也没有提供有关杜宾在交易后持有的股票数量的信息。
Virpax Pharmicals, Inc. [VRPX] 的举报人迈克尔·杜宾于2024年1月29日执行了一项交易。公告中没有披露交易的细节，包括所涉及的股票数量、股票的性质、交易价格和股票的总价值。没有具体说明迈克尔·杜宾与发行人的关系，也没有提供有关杜宾在交易后持有的股票数量的信息。
有用
没用